Barclays »

Tevogen Bio Hldgs shares owned by Barclays

Quarter-by-quarter ownership of Tevogen Bio Hldgs (TVGN) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Tevogen Bio Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Tevogen Bio Hldgs held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tevogen Bio Hldgs by Barclays

Quarter filed Position value Share count Share price at filing
2026-06-30 $198 33 6.00
2026-03-31 $1.1k 249 4.52

More positions owned by Barclays

STATE STR SPDR S&ampP 500 ETF T Fund (SPY)
Ishares Tr Opt Call Option (EEM)
Microsoft Corp Opt Call Option (MSFT)
Invesco Qqq Tr Fund (QQQ)
Ishares Tr Fund (IWM)
Nvidia Corporation Opt Call Option (NVDA)
Micron Technology (MU)
Apple (AAPL)
Alphabet Inc Class A cs (GOOGL)
Amazon Opt Put Option (AMZN)
Vaneck Etf Trust Opt Put Option (SMH)
Tesla Motors (TSLA)
Advanced Micro Devices Opt Put Option (AMD)
Broadcom Opt Put Option (AVGO)
Ishares Tr Opt Call Option (HYG)

View all positions for Barclays

Top funds holding Tevogen Bio Hldgs

Vanguard Capital Management
AQR Capital Management
Goldman Sachs Group
Jane Street
FMR
Russell Investments
Tower Research Capital
UBS Group
Vanguard Fiduciary Trust
SRS Capital Advisors
Jpmorgan Chase & Co
Royal Bank of Canada
Bnp Paribas Arbitrage, Snc
Hanson McClain Advisors
Barclays

View all funds holding Tevogen Bio Hldgs